Granite FO LLC’s Novo Nordisk NVO Stock Holding History

Granite FO LLC’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$22.4K	Hold	590	–	–	0.01%	88
2026 Q2	$28.3K	Hold	590	–	–	0.02%	85
2026 Q1	$21.7K	Hold	590	–	–	0.01%	88
2025 Q4	$30K	Hold	590	–	–	0.02%	89
2025 Q3	$32.7K	Hold	590	–	–	0.02%	93
2025 Q2	$40.7K	Hold	590	–	–	0.02%	90
2025 Q1	$41K	Hold	590	–	–	0.02%	87
2024 Q4	$50.8K	Hold	590	–	–	0.03%	84
2024 Q3	$70.3K	Buy	+590	New	+$78.7K	0.04%	79
2024 Q2	–	Sell	-590	Closed	-$79.3K	–	150
2024 Q1	$79.3K	Sell	590 -450	-43%	-$53.6K	0.05%	76
2023 Q4	$108K	Sell	1,040 -250	-19%	-$24.7K	0.07%	71
2023 Q3	$117K	Hold	1,290	–	–	0.08%	69
2023 Q2	$104K	Hold	1,290	–	–	0.07%	75
2023 Q1	$108K	Hold	1,290	–	–	0.07%	114
2022 Q4	$80.4K	Buy	+1,290	New	+$75.6K	0.06%	84

Other funds holding NVO

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return

Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.11B AUM 22.59% 1-Year Est. Return

Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return

Corda Investment Management Houston, Texas $1.52B AUM 30.53% 1-Year Est. Return

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Granite FO LLC's NVO Position: Q3 2026 in Review

Granite FO LLC held its Novo Nordisk (NVO) position steady in Q3 2026 at 590 shares worth $22.4K. The position accounts for 0.01% of the portfolio, ranked #88.

Granite FO LLC first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $117K in Q3 2023. 573 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Granite FO LLC held 590 shares of Novo Nordisk worth $22.4K as of Q3 2026.
Granite FO LLC left its Novo Nordisk share count unchanged in Q3 2026.
Novo Nordisk made up 0.01% of Granite FO LLC's portfolio in Q3 2026, its #88 holding.
Granite FO LLC first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
Granite FO LLC's Novo Nordisk position peaked at $117K in Q3 2023.
573 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Granite FO LLC's 13F filing for Q3 2026, filed 14 Oct 2026.